A synthetic peptide for use as a blocking control in assays to test for specificity of CST9 antibody, Alternative Names: Cystatin 9 control peptide, Cystatin 9 antibody Blocking Peptide, Anti-Cystatin 9 Blocking Peptide, CLM Blocking Peptide, Testatin Blocking Peptide, CST9 Blocking Peptide, Cystatin 9, Cystatin -9, Cystatin 9, Cystatin -9 Blocking Peptide, Cystatin 9 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
CST9
(Cystatin 9 (Testatin) (CST9))
Hintergrund
CST9 is part of the cystatin superfamily which encompasses proteins that contain multiple cystatin-like sequences. Some of the members are active cysteine protease inhibitors, while others have lost or perhaps never acquired this inhibitory activity. There are three inhibitory families in the superfamily, including the type 1 cystatins (stefins), type 2 cystatins and the kininogens. The type 2 cystatin proteins are a class of cysteine proteinase inhibitors found in a variety of human fluids and secretions, where they appear to provide protective functions.